These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 22223502)

  • 1. [Perspective of pathophysiology and treatment of migraine].
    Shimizu T; Suzuki N
    Brain Nerve; 2012 Jan; 64(1):59-64. PubMed ID: 22223502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Migraine: advances in the pathophysiology and treatment].
    Shimizu T; Shibata M; Suzuki N
    Rinsho Shinkeigaku; 2011 Feb; 51(2):103-9. PubMed ID: 21404609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current understanding of trigeminal ganglion structure and function in headache.
    Messlinger K; Russo AF
    Cephalalgia; 2019 Nov; 39(13):1661-1674. PubMed ID: 29989427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Trigeminovascular Pathway: Role of CGRP and CGRP Receptors in Migraine.
    Edvinsson L
    Headache; 2017 May; 57 Suppl 2():47-55. PubMed ID: 28485848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cortical spreading depression as a site of origin for migraine: Role of CGRP.
    Close LN; Eftekhari S; Wang M; Charles AC; Russo AF
    Cephalalgia; 2019 Mar; 39(3):428-434. PubMed ID: 29695168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genes, proteases, cortical spreading depression and migraine: impact on pathophysiology and treatment.
    Moskowitz MA
    Funct Neurol; 2007; 22(3):133-6. PubMed ID: 17925161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [CGRP antagonists: novel concept for treatment of migraine].
    Nieber K
    Med Monatsschr Pharm; 2009 May; 32(5):182-5. PubMed ID: 19469188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calcitonin gene-related peptide antagonists as treatments of migraine and other primary headaches.
    Goadsby PJ
    Drugs; 2005; 65(18):2557-67. PubMed ID: 16392873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective inhibition of 5-HT7 receptor reduces CGRP release in an experimental model for migraine.
    Wang X; Fang Y; Liang J; Yin Z; Miao J; Luo N
    Headache; 2010 Apr; 50(4):579-87. PubMed ID: 20236348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical localization of the calcitonin gene-related peptide binding site in the primate trigeminovascular system using functional antagonist antibodies.
    Miller S; Liu H; Warfvinge K; Shi L; Dovlatyan M; Xu C; Edvinsson L
    Neuroscience; 2016 Jul; 328():165-83. PubMed ID: 27155150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trigeminal ganglion neurons are directly activated by influx of CSF solutes in a migraine model.
    Kaag Rasmussen M; Møllgård K; Bork PAR; Weikop P; Esmail T; Drici L; Wewer Albrechtsen NJ; Carlsen JF; Huynh NPT; Ghitani N; Mann M; Goldman SA; Mori Y; Chesler AT; Nedergaard M
    Science; 2024 Jul; 385(6704):80-86. PubMed ID: 38963846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cortical spreading depression and calcitonin gene-related peptide: a brief review of current progress.
    Wang M
    Neuropeptides; 2013 Dec; 47(6):463-6. PubMed ID: 24220568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcitonin gene-related peptide enhances release of native brain-derived neurotrophic factor from trigeminal ganglion neurons.
    Buldyrev I; Tanner NM; Hsieh HY; Dodd EG; Nguyen LT; Balkowiec A
    J Neurochem; 2006 Dec; 99(5):1338-50. PubMed ID: 17064360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Application of CGRP-Related Monoclonal Antibodies in Migraine Management].
    Shibata M
    Brain Nerve; 2021 Apr; 73(4):327-337. PubMed ID: 33824220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Critical role of calcitonin gene-related peptide receptors in cortical spreading depression.
    Tozzi A; de Iure A; Di Filippo M; Costa C; Caproni S; Pisani A; Bonsi P; Picconi B; Cupini LM; Materazzi S; Geppetti P; Sarchielli P; Calabresi P
    Proc Natl Acad Sci U S A; 2012 Nov; 109(46):18985-90. PubMed ID: 23112192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Up-regulation of calcitonin gene-related peptide in trigeminal ganglion following chronic exposure to paracetamol in a CSD migraine animal model.
    Yisarakun W; Chantong C; Supornsilpchai W; Thongtan T; Srikiatkhachorn A; Reuangwechvorachai P; Maneesri-le Grand S
    Neuropeptides; 2015 Jun; 51():9-16. PubMed ID: 25998753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Basic mechanisms of migraine and its acute treatment.
    Edvinsson L; Villalón CM; MaassenVanDenBrink A
    Pharmacol Ther; 2012 Dec; 136(3):319-33. PubMed ID: 22939884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CGRP receptor antagonists and antibodies against CGRP and its receptor in migraine treatment.
    Edvinsson L
    Br J Clin Pharmacol; 2015 Aug; 80(2):193-9. PubMed ID: 25731075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different trigemino-vascular responsiveness between adolescent and adult rats in a migraine model.
    Fan PC; Kuo PH; Hu JW; Chang SH; Hsieh ST; Chiou LC
    Cephalalgia; 2012 Oct; 32(13):979-90. PubMed ID: 22843221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CGRP mechanism antagonists and migraine management.
    Karsan N; Goadsby PJ
    Curr Neurol Neurosci Rep; 2015 May; 15(5):25. PubMed ID: 25790955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.